"Gadolinium DTPA" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A complex of gadolinium with a chelating agent, diethylenetriamine penta-acetic acid (DTPA see PENTETIC ACID), that is given to enhance the image in cranial and spinal MRIs. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)
| Descriptor ID |
D019786
|
| MeSH Number(s) |
D02.092.782.590.401 D02.241.081.018.639.400 D02.691.400
|
| Concept/Terms |
Gadolinium DTPA- Gadolinium DTPA
- DTPA, Gadolinium
- Gadolinium Diethylenetriaminepenta-acetic Acid
- Diethylenetriaminepenta-acetic Acid, Gadolinium
- Gadolinium Diethylenetriaminepenta acetic Acid
- Gadopentetic Acid
- Gd-DTPA
- Gd DTPA
Gadopentetate Dimeglumine- Gadopentetate Dimeglumine
- Dimeglumine, Gadopentetate
- Gadolinium DTPA Dimeglumine Salt
- Gadolinium DTPA Dimeglumine
- Dimeglumine, Gadolinium DTPA
|
Below are MeSH descriptors whose meaning is more general than "Gadolinium DTPA".
Below are MeSH descriptors whose meaning is more specific than "Gadolinium DTPA".
This graph shows the total number of publications written about "Gadolinium DTPA" by people in this website by year, and whether "Gadolinium DTPA" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2005 | 2 | 1 | 3 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 2 | 3 |
| 2011 | 0 | 3 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 2 | 2 |
| 2016 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gadolinium DTPA" by people in Profiles.
-
Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents. Eur Radiol. 2020 Mar; 30(3):1790-1803.
-
Myocardial Extracellular Volume Fraction Adds Prognostic Information Beyond Myocardial Replacement Fibrosis. Circ Cardiovasc Imaging. 2019 12; 12(12):e009535.
-
Tumor Contrast Enhancement and Whole-Body Elimination of the Manganese-Based Magnetic Resonance Imaging Contrast Agent Mn-PyC3A. Invest Radiol. 2019 11; 54(11):697-703.
-
Genetic variants of HIF1a are associated with right ventricular fibrotic load in repaired tetralogy of Fallot patients: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2019 08 19; 21(1):51.
-
Evaluation of Gadolinium Deposition in the Brain After MR Arthrography. AJR Am J Roentgenol. 2018 11; 211(5):1063-1067.
-
Characterization of a novel MR-detectable nanoantioxidant that mitigates the recall immune response. NMR Biomed. 2016 10; 29(10):1436-44.
-
Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy. Am J Cardiol. 2016 Apr 15; 117(8):1342-8.
-
Feature Tracking-Derived Peak Systolic Strain Compared to Late Gadolinium Enhancement in Troponin-Positive Myocarditis: A Case-Control Study. Pediatr Cardiol. 2016 Apr; 37(4):696-703.
-
Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI. Br J Cancer. 2015 Nov 03; 113(9):1282-8.
-
Two-dimensional speckle-tracking-derived segmental peak systolic longitudinal strain identifies regional myocardial involvement in patients with myocarditis and normal global left ventricular systolic function. Pediatr Cardiol. 2015 Jun; 36(5):950-9.